Therefore, the previously reported elevations of VEGF and pro-inflammatory cytokines in SLE patients also align with the increased risk of atherosclerosis and cardiovascular disease in this group [4–7, 13, 22]. This evidence concerns the gene VEGFA and systemic lupus erythematosus.